Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Institutional Investor > Bios Capital Management, Lp > Profile

Instuitional Investor - Bios Capital Management, Lp

Profile
13F Holdings

Fund Profile

Filing Period:

Fund Name:	Bios Capital Management, Lp
Portfolio Value	$52,866,306

Top 13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Actuate Therapeutics Inc.	ACTU	10,049,996	$27,536,989	52.09%
2.	Opus Genetics Inc.	IRD	3,683,429	$16,759,602	31.7%
3.	Cognition Therapeutics Inc	CGTX	6,000,000	$4,560,000	8.63%
4.	Rein Therapeutics Inc.	RNTX	1,982,375	$2,577,088	4.87%
5.	Lantern Pharma Inc.	LTRN	864,435	$1,184,276	2.24%